CSIMarket
 



<< Back to Financial Strength by Company within Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry Financial Strength Information

Financial Strength Information & Trends  
 


Category:   Period:  

Biotechnology & Pharmaceuticals Industry 4 Q 3 Q 2 Q 1 Q 4 Q
  2018 2018 2018 2018 2017
Quick Ratio (TTM) 1.59 1.64 1.75 1.88 1.92
Quick Ratio Ranking # 8 # 8 # 8 # 5 # 4
Working Capital Ratio (TTM) 2.3 2.35 2.48 2.64 2.72
Working Capital Ratio Ranking # 14 # 14 # 14 # 9 # 7
Working Capital Per Revenue 0.58 0.61 0.65 0.7 0.71
Working Capital Per Revenue Ranking # 96 # 94 # 94 # 97 # 95
Leverage Ratio (TTM) 1.66 1.62 1.54 1.46 1.39
Leverage Ratio Ranking # 46 # 45 # 38 # 33 # 30
Total Debt to Equity (TTM) 0.11 0.1 0.09 0.08 0.07
Total Debt to Equity Ranking # 63 # 73 # 71 # 62 # 57
Interest Coverage (TTM) 13.22 18.04 14.77 15.16 15.01
Interest Coverage Ranking # 37 # 20 # 28 # 23 # 30
Debt Coverage (TTM) 1.87 2.63 2.28 2.69 2.76
Debt Coverage Ranking # 74 # 79 # 84 # 78 # 78


Quick Ratio Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the 4 Q 2018, Quick Ratio fell to 1.59 below Biotechnology & Pharmaceuticals Industry average.



Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest Quick Ratio. Total ranking remained unchanged relative to the quarter before at no. 8.

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Quick Ratio Statistics as of 4 Q 2018
High Average Low
37.9 3 0.76
1. quarter 2016   4. quarter 2021

Quick Ratio Industry Ranking
Within: No.
Sector # 1
Overall # 8


Other Quick Ratios
Compare Industry's quick ratio to Bkkt's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Highest Ranking Quick Ratios Lowest Ranking Quick Ratios
Quick Ratios for BKKT's Competitors Definiton of Quick Ratio


Biotechnology & Pharmaceuticals Industry Working Capital Ratio Statistics as of 4 Q 2018
 



Working Capital Ratio Statistics as of 4 Q 2018
High Average Low
4.83 2.5 1.7
1. quarter 2016   2. quarter 2021



Working Capital Ratio Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the 4 Q 2018, Working Capital Ratio fell to 2.3 below Biotechnology & Pharmaceuticals Industry average.



Within Healthcare sector only one Industry has achieved higher Working Capital Ratio. Total ranking remained unchanged from the previous quarter at no. 14.



Working Capital Ratio Industry Ranking
Within: No.
Sector # 2
Overall # 14

Other Working Capital Ratios
Highest Ranking Working Capital Ratios Lowest Ranking Working Capital Ratios
Compare Industry's Working Capital ratio to Bkkt's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Working Capital ratios for BKKT's Competitors Definiton of Working Capital Ratio

Biotechnology & Pharmaceuticals Industry Working Capital Per Revenue Statistics as of 4 Q 2018
 
Working Capital Per Revenue Comment
On the trailing twelve months basis Biotechnology & Pharmaceuticals Industry's Working Capital Per Revenue sequentially decreased to 0.58 in the 4 Q 2018, but remained above Industry average.



Within Healthcare sector 5 other industries have achieved lower Working Capital Per Revenue. Working Capital Per Revenue total ranking fell in contrast to the preceding quarter from 94 to 96.




Working Capital Per Revenue Statistics as of 4 Q 2018
High Average Low
0.94 0.54 0.06
3. quarter 2023   1. quarter 2016


Working Capital Per Revenue Industry Ranking
Within: No.
Sector # 6
Overall # 96



Other Working Capital Per Revenue
Compare Industry's Working Capital Per Revenue to Bkkt's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Return On Assets for Biotechnology & Pharmaceuticals Industry Definiton of Working Capital Per Revenue



Biotechnology & Pharmaceuticals Industry Leverage Ratio Statistics as of 4 Q 2018
 


Leverage Ratio Statistics as of 4 Q 2018
High Average Low
4.67 1.61 -0.88
3. quarter 2023   1. quarter 2016



Leverage Ratio Comment
Due to cumulative net new borrowings of -0.98% in the 4 Q 2018, Liabilities to Equity ratio increased to 1.66, above Biotechnology & Pharmaceuticals Industry average.



Among other Industries in the Healthcare sector 4 other industries have achieved lower Leverage Ratio.



Leverage Ratio overall ranking has fallen relative to the prior quarter from 45 to 46.



Leverage Ratio Industry Ranking
Within: No.
Sector # 5
Overall # 46

Other Leverage Ratios
Compare Industry's Leverage ratio to Bkkt's or S&P Bond Interest rates
Highest Ranking Leverage Ratios Lowest Ranking Leverage Ratios
Leverage Ratios for BKKT's Competitors What is Leverage Ratio?


Biotechnology & Pharmaceuticals Industry Total Debt to Equity Ratio Statistics as of 4 Q 2018
 
Debt to Equity Ratio Comment
Due to net new borrowings of 1.48%, Total Debt to Equity detoriated to 0.11 in the 4 Q 2018, below Industry average.



Within Healthcare sector 4 other industries have achieved lower Debt to Equity Ratio. Debt to Equity Ratio total ranking has improved so far to 63, from total ranking in previous quarter at 73.




Debt to Equity Ratio Statistics as of 4 Q 2018
High Average Low
3.21 0.4 0.03
3. quarter 2023   3. quarter 2021



Debt to Equity Industry Ranking
Within: No.
Sector # 5
Overall # 63

Other Debt to Equity Ratios
Highest Ranking Debt to Equity Ratios Lowest Ranking Debt to Equity Ratios
Compare Industry's Debt to Equity ratio to Bkkt's or S&P Definiton of Debt to Equity Ratio

Biotechnology & Pharmaceuticals Industry Interest Coverage Ratio Statistics as of 4 Q 2018
 


Interest Coverage Ratio Statistics as of 4 Q 2018
High Average Low
24.92 8.57 -89.62
2. quarter 2016   3. quarter 2016

Interest Coverage Ratio Comment
On the trailing twelve months basis Despite sequential decrease in interest expenses, Interest Coverage Ratio detoriated to 13.22 in the 4 Q 2018, above Biotechnology & Pharmaceuticals Industry average.



In the Healthcare sector only one Industry has achieved higher Interest Coverage Ratio. Interest Coverage overall ranking fell in contrast to the prior period from 20 to 37.



Interest Coverage Ratio Industry Ranking
Within: No.
Sector # 2
Overall # 37

Other Interest Coverage Ratios
Highest Ranking Interest Coverage Ratios Lowest Ranking Interest Coverage Ratios
Compare Industry's Interest Coverage ratio to Bkkt's or S&P Definiton of Interest Coverage Ratio


Biotechnology & Pharmaceuticals Industry Debt Coverage Statistics as of 4 Q 2018
 
Debt Coverage Ratio Comment
On the trailing twelve months basis Due to increase in total debt in 4 Q 2018, Debt Coverage Ratio fell to 1.87 below Biotechnology & Pharmaceuticals Industry average.



Looking into Healthcare sector 5 other industries have achieved higher debt coverage ratio. Debt Coverage Ratio total ranking has improved to 74, from total ranking in previous quarter at 79.




Debt Coverage Statistics as of 4 Q 2018
High Average Low
8.77 1.93 -0.13
3. quarter 2021   4. quarter 2015



Debt Coverage Industry Ranking
Within: No.
Sector # 6
Overall # 74

Other Debt Coverage Ratios
Highest Ranking Debt Coverage Ratios Lowest Ranking Debt Coverage Ratios
See also Biotechnology & Pharmaceuticals Industry's Margin Definiton of Debt Coverage Ratio

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com